Press Releases

Date	Title	Company
05-Jul-2023	Global Nanoparticle Formulation Market Report 2023: Rising Interest in Nanoparticle-based Vaccines to Drive Growth - ResearchAndMarkets.com	Businesswire
05-Jul-2023	Buffer Preparation Market Report 2023: Industry Trends and Global Forecasts - ResearchAndMarkets.com	Businesswire
05-Jul-2023	ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.	Businesswire
05-Jul-2023	Coya Therapeutics (“Coya”) Appoints Industry and Drug Development Veteran, Dr. Fred Grossman, to President and Chief Medical Officer succeeding Dr. Adrian Hepner	Businesswire
05-Jul-2023	MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals	Businesswire
05-Jul-2023	Oncoinvent appoints Anders Månsson as CEO	Businesswire
05-Jul-2023	New Microbiology and Chemistry Laboratory Opens to Accelerate Scientific Discovery	Businesswire
05-Jul-2023	Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023	Businesswire
05-Jul-2023	Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics	Businesswire
05-Jul-2023	Global Chlor Alkali Market Report 2023: Sector is Expected to Reach $103.07 Billion by 2028 - ResearchAndMarkets.com	Businesswire
05-Jul-2023	Management Consulting Global Market to 2028: Growing Need for Digital Consultancy Fuels the Sector - ResearchAndMarkets.com	Businesswire
05-Jul-2023	Research from the Lab of CAMP4 Co-Founder Richard Young Shows That RNA Binding to Transcription Factors Fine-Tunes Gene Expression	Businesswire
05-Jul-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
05-Jul-2023	REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator	Businesswire
05-Jul-2023	KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Businesswire
05-Jul-2023	Kashiv Biosciences Announces Successful Phase 1 Study Results of ADL018, A Biosimilar Candidate to Xolair® (omalizumab)	Businesswire
05-Jul-2023	Roland Corporation Fine Tunes Translation With Language Weaver	Businesswire
05-Jul-2023	European Commission Approves ORKAMBI® (lumacaftor/ivacaftor) for the Treatment of Children With Cystic Fibrosis Ages 1 to <2 Years Old	Businesswire
05-Jul-2023	Driving Muscle Performance: Muscle Stimulation Devices Market Estimated to Reach US$ 874.4 Million by 2028	MARKITWIRED
05-Jul-2023	Transforming Trauma Treatment: Orthopedic Trauma Devices Market Set to Achieve a CAGR of 7.1% from 2023 to 2033	MARKITWIRED